163 related articles for article (PubMed ID: 12902856)
1. Development of COX inhibitors in cancer prevention and therapy.
Umar A; Viner JL; Anderson WF; Hawk ET
Am J Clin Oncol; 2003 Aug; 26(4):S48-57. PubMed ID: 12902856
[TBL] [Abstract][Full Text] [Related]
2. Use of NSAIDs for the chemoprevention of colorectal cancer.
Herendeen JM; Lindley C
Ann Pharmacother; 2003 Nov; 37(11):1664-74. PubMed ID: 14565811
[TBL] [Abstract][Full Text] [Related]
3. COX-2 inhibitor as a radiation enhancer: new strategies for the treatment of lung cancer.
Saha D; Pyo H; Choy H
Am J Clin Oncol; 2003 Aug; 26(4):S70-4. PubMed ID: 12902860
[TBL] [Abstract][Full Text] [Related]
4. An introduction to aspirin, NSAids, and COX-2 inhibitors for the primary prevention of cardiovascular events and cancer and their potential preventive role in bladder carcinogenesis: part II.
Moyad MA
Semin Urol Oncol; 2001 Nov; 19(4):306-16. PubMed ID: 11769882
[TBL] [Abstract][Full Text] [Related]
5. Clinical pharmacology of selective COX-2 inhibitors.
Capone ML; Tacconelli S; Sciulli MG; Patrignani P
Int J Immunopathol Pharmacol; 2003; 16(2 Suppl):49-58. PubMed ID: 14552704
[TBL] [Abstract][Full Text] [Related]
6. Use of nonsteroidal anti-inflammatory drugs and cyclooxygenase-2 (COX-2) inhibitors: indications and complications.
Pascucci RA
J Am Osteopath Assoc; 2002 Sep; 102(9):487-9. PubMed ID: 12361181
[TBL] [Abstract][Full Text] [Related]
7. Colorectal cancer prevention and treatment by inhibition of cyclooxygenase-2.
Gupta RA; Dubois RN
Nat Rev Cancer; 2001 Oct; 1(1):11-21. PubMed ID: 11900248
[TBL] [Abstract][Full Text] [Related]
8. COX-2 inhibitors as radiosensitizing agents for cancer therapy.
Davis TW; Hunter N; Trifan OC; Milas L; Masferrer JL
Am J Clin Oncol; 2003 Aug; 26(4):S58-61. PubMed ID: 12902857
[TBL] [Abstract][Full Text] [Related]
9. Non-COX-2 targets and cancer: expanding the molecular target repertoire of chemoprevention.
Kashfi K; Rigas B
Biochem Pharmacol; 2005 Oct; 70(7):969-86. PubMed ID: 15949789
[TBL] [Abstract][Full Text] [Related]
10. COX-2: a target for prevention and treatment of esophageal cancer.
Altorki N
J Surg Res; 2004 Mar; 117(1):114-20. PubMed ID: 15013721
[No Abstract] [Full Text] [Related]
11. Novel approaches for colon cancer prevention by cyclooxygenase-2 inhibitors.
Reddy BS; Rao CV
J Environ Pathol Toxicol Oncol; 2002; 21(2):155-64. PubMed ID: 12086402
[TBL] [Abstract][Full Text] [Related]
12. Cyclooxygenase-2 as a potential target in the prevention and treatment of genitourinary tumors: a review.
Pruthi RS; Derksen E; Gaston K
J Urol; 2003 Jun; 169(6):2352-9. PubMed ID: 12771797
[TBL] [Abstract][Full Text] [Related]
13. Why cyclooxygenase-2 inhibition plus chemotherapy?
Sweeney CJ
Am J Clin Oncol; 2003 Aug; 26(4):S122-5. PubMed ID: 12902869
[TBL] [Abstract][Full Text] [Related]
14. COX-2: a molecular target for colorectal cancer prevention.
Brown JR; DuBois RN
J Clin Oncol; 2005 Apr; 23(12):2840-55. PubMed ID: 15837998
[TBL] [Abstract][Full Text] [Related]
15. Anti-metastatic action of non-steroidal anti-inflammatory drugs.
Hung WC
Kaohsiung J Med Sci; 2008 Aug; 24(8):392-7. PubMed ID: 18926952
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of tumor angiogenesis by non-steroidal anti-inflammatory drugs: emerging mechanisms and therapeutic perspectives.
Dermond O; Rüegg C
Drug Resist Updat; 2001 Oct; 4(5):314-21. PubMed ID: 11991685
[TBL] [Abstract][Full Text] [Related]
17. Cyclooxygenase-2-selective nonsteroidal anti-inflammatory drugs inhibit hepatocyte growth factor/scatter factor-induced angiogenesis.
Sengupta S; Sellers LA; Cindrova T; Skepper J; Gherardi E; Sasisekharan R; Fan TP
Cancer Res; 2003 Dec; 63(23):8351-9. PubMed ID: 14678996
[TBL] [Abstract][Full Text] [Related]
18. Cancer prevention: a new era beyond cyclooxygenase-2.
Rigas B; Kashfi K
J Pharmacol Exp Ther; 2005 Jul; 314(1):1-8. PubMed ID: 15805430
[TBL] [Abstract][Full Text] [Related]
19. Utilization of nonsteroidal anti-inflammatory drugs and antisecretory agents: a managed care claims analysis.
Ofman JJ; Badamgarav E; Henning JM; Knight K; Laine L
Am J Med; 2004 Jun; 116(12):835-42. PubMed ID: 15178499
[TBL] [Abstract][Full Text] [Related]
20. Celecoxib: a potent cyclooxygenase-2 inhibitor in cancer prevention.
Kismet K; Akay MT; Abbasoglu O; Ercan A
Cancer Detect Prev; 2004; 28(2):127-42. PubMed ID: 15068837
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]